---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-047422"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2024-11-22T23:59:59+00:00"
generated_at: "2026-05-29T19:56:59.935317+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Indaptus Therapeutics prices $2.135M offering of stock and warrants at $1.175/unit

## Summary
- Sold 1,817,017 shares of common stock and warrants to buy 1,817,017 shares at $1.175 per unit.
- Warrants exercisable at $1.05/share, immediately exercisable, 5-year term; gross proceeds ~$2.135M.
- CEO participating, purchasing 42,553 shares and warrants on same terms as other investors.
- Funds to be used for R&D, working capital, and general corporate purposes.
- Closing expected November 25, 2024; Paulson Investment Company acting as exclusive placement agent.

## SEC filing metadata
- accession: 0001493152-24-047422
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2024-11-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000149315224047422/0001493152-24-047422-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000149315224047422/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-047422
- JSON: https://secwatch.observer/filing/0001493152-24-047422.json
- Plain text: https://secwatch.observer/filing/0001493152-24-047422.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.